Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-04

FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for Sevelamer Carbonate by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

SUPPL AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)